VISIA Imaging is proud to say that Bio-Rad Laboratories has entered into an agreement that gives it commercialization rights to VISIA Imaging's second-generation immunofluorescence slide processing and reading platform for the evaluation of autoimmune diseases.
VISIA Imaging is one of the beneficiaries of the European
Regional Development Fund (ERDF), as a winner of the
"Programma Operativo Regionale, Crescita e Occupazione" (POR-CreO
Visia Imaging has realized a feasibility study aimed at presenting the GENIUS project under the Horizon 2020 SME program.
The feasibility study was co-funded by POR CREO 2014-2020, Call for Innovation through the project "Visia4EUROPE"
VISIA Imaging is pleased to announce that its integrated biometer and
corneal analyser ALADDIN HW3.0 has received 510(k)
clearance from the U.S. Food and Drug Administration
Navigate and manage images in the same way as a traditional
Focus, magnify, reduce, zoom, stop on a field, a
detail, or scan rapidly, high fidelity digital images at your
Navigo is a brand-new compact slide scanner for digital pathology
allowing fast, flexible and reliable acquisition, navigation, analysis,
archiving and transfer of high quality digital images. >>
VISIA Imaging headquarters are in San Giovanni Valdarno (AR), Italy.
The company has recently moved into a new building. >>